Search for: "In re: S.D. & S.D" Results 41 - 60 of 830
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2023, 5:59 am by Kevin LaCroix
Specifically, Vice Chancellor Laster’s October 25, 2022 opinion in the longstanding litigation styled, In Re: P3 Health Group Holdings LLC holds that individual partners of the sponsor without a formal appointment or role at the portfolio company could be subject to exposure as “acting managers” of the portfolio company in connection with their management or operation of the portfolio company under Delaware law. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
7 Feb 2023, 12:00 pm by Bernard Bell
May an agency revive a defunct rulemaking without notice, and then immediately promulgate a lightly revised version of the proposed rule as a final rule? [read post]
18 Dec 2022, 3:52 pm by admin
[J&J], a manufacturer and seller of cosmetic talc. [read post]
3 Oct 2022, 12:04 pm by admin
In “Cheng’s Proposed Consensus Rule for Expert Witnesses,”[1] I discussed a recent law review article by Professor Edward K. [read post]
13 Sep 2022, 3:00 am by Jack Sharman
  Jack Sharman is chair of the White-Collar Criminal Defense and Corporate Investigations practice group at Lightfoot, Franklin & White LLC. [read post]
8 Sep 2022, 5:35 am by Jack Goldsmith
If so, they may publish if they know they're protected by the "actual malice" standard, but refrain from publishing if they are subject to the negligence standard. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
  These companies have historically been considered attractive targets for securities actions given the inherent risks of the industry and the volatility of their stock prices, and, as a result, often have relatively limited D&O insurance options. [read post]